nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CACNA1D—cochlea—hypothyroidism	0.0405	0.0928	CbGeAlD
Nimodipine—Phlebitis—Liothyronine—hypothyroidism	0.0283	0.0672	CcSEcCtD
Nimodipine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0269	0.0638	CcSEcCtD
Nimodipine—Wheezing—Levothyroxine—hypothyroidism	0.016	0.038	CcSEcCtD
Nimodipine—Wheezing—Dextrothyroxine—hypothyroidism	0.016	0.038	CcSEcCtD
Nimodipine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.0132	0.0313	CcSEcCtD
Nimodipine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.0132	0.0313	CcSEcCtD
Nimodipine—NR3C2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0127	0.0892	CbGpPWpGaD
Nimodipine—Hypertension—Liothyronine—hypothyroidism	0.0127	0.0301	CcSEcCtD
Nimodipine—Wheezing—Liotrix—hypothyroidism	0.0118	0.028	CcSEcCtD
Nimodipine—Tachycardia—Liothyronine—hypothyroidism	0.0117	0.0278	CcSEcCtD
Nimodipine—Fluid retention—Liotrix—hypothyroidism	0.0115	0.0273	CcSEcCtD
Nimodipine—CACNA1S—heart—hypothyroidism	0.0115	0.0264	CbGeAlD
Nimodipine—NR3C2—Preimplantation Embryo—DLX2—hypothyroidism	0.0115	0.0805	CbGpPWpGaD
Nimodipine—Hypotension—Liothyronine—hypothyroidism	0.0112	0.0266	CcSEcCtD
Nimodipine—CACNA1S—cardiovascular system—hypothyroidism	0.0109	0.0249	CbGeAlD
Nimodipine—Lightheadedness—Liotrix—hypothyroidism	0.0109	0.0258	CcSEcCtD
Nimodipine—CACNB1—heart—hypothyroidism	0.0107	0.0246	CbGeAlD
Nimodipine—CACNB3—heart—hypothyroidism	0.0103	0.0236	CbGeAlD
Nimodipine—Phlebitis—Liotrix—hypothyroidism	0.0102	0.0243	CcSEcCtD
Nimodipine—CACNB1—cardiovascular system—hypothyroidism	0.0101	0.0232	CbGeAlD
Nimodipine—Sweating increased—Dextrothyroxine—hypothyroidism	0.0101	0.0239	CcSEcCtD
Nimodipine—Sweating increased—Levothyroxine—hypothyroidism	0.0101	0.0239	CcSEcCtD
Nimodipine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00971	0.0231	CcSEcCtD
Nimodipine—CACNB4—thyroid gland—hypothyroidism	0.00968	0.0222	CbGeAlD
Nimodipine—CACNB3—pituitary gland—hypothyroidism	0.00861	0.0197	CbGeAlD
Nimodipine—CACNB4—testis—hypothyroidism	0.0083	0.019	CbGeAlD
Nimodipine—CACNA1S—thyroid gland—hypothyroidism	0.00829	0.019	CbGeAlD
Nimodipine—NR3C2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00819	0.0575	CbGpPWpGaD
Nimodipine—CYP3A4—urine—hypothyroidism	0.00805	0.0184	CbGeAlD
Nimodipine—CACNB1—adrenal gland—hypothyroidism	0.00802	0.0184	CbGeAlD
Nimodipine—AHR—adrenal cortex—hypothyroidism	0.00789	0.0181	CbGeAlD
Nimodipine—NR3C2—Preimplantation Embryo—NKX2-1—hypothyroidism	0.00774	0.0544	CbGpPWpGaD
Nimodipine—CACNB1—thyroid gland—hypothyroidism	0.00773	0.0177	CbGeAlD
Nimodipine—CACNB3—adrenal gland—hypothyroidism	0.00769	0.0176	CbGeAlD
Nimodipine—Flushing—Levothyroxine—hypothyroidism	0.00769	0.0182	CcSEcCtD
Nimodipine—Flushing—Dextrothyroxine—hypothyroidism	0.00769	0.0182	CcSEcCtD
Nimodipine—CACNB3—blood—hypothyroidism	0.00769	0.0176	CbGeAlD
Nimodipine—CACNB4—cerebellum—hypothyroidism	0.00767	0.0176	CbGeAlD
Nimodipine—AHR—heart—hypothyroidism	0.00763	0.0175	CbGeAlD
Nimodipine—CACNB1—female gonad—hypothyroidism	0.00747	0.0171	CbGeAlD
Nimodipine—CACNB3—thyroid gland—hypothyroidism	0.00742	0.017	CbGeAlD
Nimodipine—Sweating increased—Liotrix—hypothyroidism	0.00741	0.0176	CcSEcCtD
Nimodipine—CACNB3—female gonad—hypothyroidism	0.00717	0.0164	CbGeAlD
Nimodipine—CACNB2—heart—hypothyroidism	0.00692	0.0159	CbGeAlD
Nimodipine—CACNB1—testis—hypothyroidism	0.00663	0.0152	CbGeAlD
Nimodipine—CACNB2—cardiovascular system—hypothyroidism	0.00653	0.015	CbGeAlD
Nimodipine—AHR—pituitary gland—hypothyroidism	0.00638	0.0146	CbGeAlD
Nimodipine—Palpitations—Dextrothyroxine—hypothyroidism	0.00637	0.0151	CcSEcCtD
Nimodipine—Palpitations—Levothyroxine—hypothyroidism	0.00637	0.0151	CcSEcCtD
Nimodipine—CACNB3—testis—hypothyroidism	0.00636	0.0146	CbGeAlD
Nimodipine—CACNA1D—adrenal cortex—hypothyroidism	0.00625	0.0143	CbGeAlD
Nimodipine—CACNB1—cerebellum—hypothyroidism	0.00612	0.014	CbGeAlD
Nimodipine—CACNB3—cerebellum—hypothyroidism	0.00587	0.0135	CbGeAlD
Nimodipine—CACNB2—pituitary gland—hypothyroidism	0.00578	0.0132	CbGeAlD
Nimodipine—Tachycardia—Levothyroxine—hypothyroidism	0.00574	0.0136	CcSEcCtD
Nimodipine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00574	0.0136	CcSEcCtD
Nimodipine—CACNA1D—cardiovascular system—hypothyroidism	0.00571	0.0131	CbGeAlD
Nimodipine—AHR—adrenal gland—hypothyroidism	0.0057	0.013	CbGeAlD
Nimodipine—AHR—blood—hypothyroidism	0.00569	0.013	CbGeAlD
Nimodipine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00569	0.0135	CcSEcCtD
Nimodipine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00569	0.0135	CcSEcCtD
Nimodipine—Flushing—Liotrix—hypothyroidism	0.00565	0.0134	CcSEcCtD
Nimodipine—CACNA1C—heart—hypothyroidism	0.00558	0.0128	CbGeAlD
Nimodipine—AHR—thyroid gland—hypothyroidism	0.0055	0.0126	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00536	0.0127	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00536	0.0127	CcSEcCtD
Nimodipine—AHR—female gonad—hypothyroidism	0.00531	0.0122	CbGeAlD
Nimodipine—CACNA1C—cardiovascular system—hypothyroidism	0.00527	0.0121	CbGeAlD
Nimodipine—NR3C2—adrenal cortex—hypothyroidism	0.00526	0.012	CbGeAlD
Nimodipine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00525	0.0125	CcSEcCtD
Nimodipine—Dyspnoea—Levothyroxine—hypothyroidism	0.00525	0.0125	CcSEcCtD
Nimodipine—CACNB2—adrenal gland—hypothyroidism	0.00517	0.0118	CbGeAlD
Nimodipine—NR3C2—heart—hypothyroidism	0.00508	0.0116	CbGeAlD
Nimodipine—CACNA1D—pituitary gland—hypothyroidism	0.00505	0.0116	CbGeAlD
Nimodipine—CACNB2—thyroid gland—hypothyroidism	0.00498	0.0114	CbGeAlD
Nimodipine—CACNB4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00484	0.034	CbGpPWpGaD
Nimodipine—NR3C2—cardiovascular system—hypothyroidism	0.0048	0.011	CbGeAlD
Nimodipine—AHR—testis—hypothyroidism	0.00471	0.0108	CbGeAlD
Nimodipine—Palpitations—Liotrix—hypothyroidism	0.00469	0.0111	CcSEcCtD
Nimodipine—CACNA1C—pituitary gland—hypothyroidism	0.00467	0.0107	CbGeAlD
Nimodipine—Hypertension—Liotrix—hypothyroidism	0.00458	0.0109	CcSEcCtD
Nimodipine—CACNA1D—adrenal gland—hypothyroidism	0.00451	0.0103	CbGeAlD
Nimodipine—AHR—liver—hypothyroidism	0.00445	0.0102	CbGeAlD
Nimodipine—CACNA1D—thyroid gland—hypothyroidism	0.00436	0.00998	CbGeAlD
Nimodipine—AHR—cerebellum—hypothyroidism	0.00435	0.00997	CbGeAlD
Nimodipine—Oedema—Liotrix—hypothyroidism	0.00433	0.0103	CcSEcCtD
Nimodipine—CACNB2—testis—hypothyroidism	0.00427	0.00979	CbGeAlD
Nimodipine—NR3C2—pituitary gland—hypothyroidism	0.00425	0.00973	CbGeAlD
Nimodipine—Tachycardia—Liotrix—hypothyroidism	0.00422	0.01	CcSEcCtD
Nimodipine—Hyperhidrosis—Liotrix—hypothyroidism	0.00418	0.00993	CcSEcCtD
Nimodipine—CACNA1C—adrenal gland—hypothyroidism	0.00417	0.00955	CbGeAlD
Nimodipine—Pruritus—Levothyroxine—hypothyroidism	0.00416	0.00988	CcSEcCtD
Nimodipine—Pruritus—Dextrothyroxine—hypothyroidism	0.00416	0.00988	CcSEcCtD
Nimodipine—Hypotension—Liotrix—hypothyroidism	0.00404	0.0096	CcSEcCtD
Nimodipine—CACNB2—liver—hypothyroidism	0.00404	0.00925	CbGeAlD
Nimodipine—Diarrhoea—Levothyroxine—hypothyroidism	0.00403	0.00956	CcSEcCtD
Nimodipine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00403	0.00956	CcSEcCtD
Nimodipine—CACNB2—cerebellum—hypothyroidism	0.00394	0.00904	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00394	0.00936	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00393	0.0276	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00387	0.0272	CbGpPWpGaD
Nimodipine—Dyspnoea—Liotrix—hypothyroidism	0.00386	0.00916	CcSEcCtD
Nimodipine—NR3C2—adrenal gland—hypothyroidism	0.00379	0.00869	CbGeAlD
Nimodipine—NR3C2—blood—hypothyroidism	0.00379	0.00869	CbGeAlD
Nimodipine—CACNB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00376	0.0264	CbGpPWpGaD
Nimodipine—Vomiting—Levothyroxine—hypothyroidism	0.00374	0.00888	CcSEcCtD
Nimodipine—Vomiting—Dextrothyroxine—hypothyroidism	0.00374	0.00888	CcSEcCtD
Nimodipine—CACNA1D—testis—hypothyroidism	0.00373	0.00856	CbGeAlD
Nimodipine—Rash—Dextrothyroxine—hypothyroidism	0.00371	0.00881	CcSEcCtD
Nimodipine—Rash—Levothyroxine—hypothyroidism	0.00371	0.00881	CcSEcCtD
Nimodipine—Dermatitis—Levothyroxine—hypothyroidism	0.00371	0.0088	CcSEcCtD
Nimodipine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00371	0.0088	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—SLC5A7—hypothyroidism	0.00371	0.026	CbGpPWpGaD
Nimodipine—Headache—Dextrothyroxine—hypothyroidism	0.00369	0.00875	CcSEcCtD
Nimodipine—Headache—Levothyroxine—hypothyroidism	0.00369	0.00875	CcSEcCtD
Nimodipine—NR3C2—thyroid gland—hypothyroidism	0.00366	0.00839	CbGeAlD
Nimodipine—NR3C2—female gonad—hypothyroidism	0.00354	0.0081	CbGeAlD
Nimodipine—CACNA1D—liver—hypothyroidism	0.00353	0.00809	CbGeAlD
Nimodipine—Nausea—Dextrothyroxine—hypothyroidism	0.0035	0.0083	CcSEcCtD
Nimodipine—Nausea—Levothyroxine—hypothyroidism	0.0035	0.0083	CcSEcCtD
Nimodipine—CACNA1D—cerebellum—hypothyroidism	0.00345	0.0079	CbGeAlD
Nimodipine—CACNA1C—testis—hypothyroidism	0.00345	0.0079	CbGeAlD
Nimodipine—NR3C2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.0034	0.0239	CbGpPWpGaD
Nimodipine—Hypersensitivity—Liotrix—hypothyroidism	0.00319	0.00757	CcSEcCtD
Nimodipine—CACNA1C—cerebellum—hypothyroidism	0.00318	0.00729	CbGeAlD
Nimodipine—NR3C2—testis—hypothyroidism	0.00314	0.00719	CbGeAlD
Nimodipine—CACNB4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00312	0.0219	CbGpPWpGaD
Nimodipine—Pruritus—Liotrix—hypothyroidism	0.00306	0.00727	CcSEcCtD
Nimodipine—NR3C2—liver—hypothyroidism	0.00297	0.0068	CbGeAlD
Nimodipine—CACNB3—Neuronal System—SLC5A7—hypothyroidism	0.00296	0.0208	CbGpPWpGaD
Nimodipine—Diarrhoea—Liotrix—hypothyroidism	0.00296	0.00703	CcSEcCtD
Nimodipine—NR3C2—cerebellum—hypothyroidism	0.0029	0.00664	CbGeAlD
Nimodipine—CACNB1—Neuronal System—SLC5A7—hypothyroidism	0.00288	0.0202	CbGpPWpGaD
Nimodipine—Dizziness—Liotrix—hypothyroidism	0.00286	0.0068	CcSEcCtD
Nimodipine—Vomiting—Liotrix—hypothyroidism	0.00275	0.00653	CcSEcCtD
Nimodipine—Rash—Liotrix—hypothyroidism	0.00273	0.00648	CcSEcCtD
Nimodipine—Dermatitis—Liotrix—hypothyroidism	0.00273	0.00647	CcSEcCtD
Nimodipine—Headache—Liotrix—hypothyroidism	0.00271	0.00644	CcSEcCtD
Nimodipine—Nausea—Liotrix—hypothyroidism	0.00257	0.0061	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00249	0.0175	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00242	0.017	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—NEFL—hypothyroidism	0.00239	0.0168	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00236	0.0166	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—CLTC—hypothyroidism	0.00228	0.016	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—THRA—hypothyroidism	0.00219	0.0154	CbGpPWpGaD
Nimodipine—CYP3A5—blood—hypothyroidism	0.00205	0.0047	CbGeAlD
Nimodipine—CYP3A5—female gonad—hypothyroidism	0.00191	0.00438	CbGeAlD
Nimodipine—CACNB3—Neuronal System—NEFL—hypothyroidism	0.00191	0.0134	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—NEFL—hypothyroidism	0.00186	0.013	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—CLTC—hypothyroidism	0.00182	0.0128	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—SLC5A7—hypothyroidism	0.00181	0.0127	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—CLTC—hypothyroidism	0.00177	0.0124	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ZNF764—hypothyroidism	0.00164	0.0115	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CLTC—hypothyroidism	0.00163	0.0114	CbGpPWpGaD
Nimodipine—CYP3A5—liver—hypothyroidism	0.0016	0.00367	CbGeAlD
Nimodipine—NR3C2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00156	0.011	CbGpPWpGaD
Nimodipine—CYP3A4—blood—hypothyroidism	0.00154	0.00353	CbGeAlD
Nimodipine—CACNB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00152	0.0107	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—AVP—hypothyroidism	0.00149	0.0105	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—THRB—hypothyroidism	0.00141	0.00993	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IGF1—hypothyroidism	0.00135	0.00949	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CLTC—hypothyroidism	0.0013	0.00913	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—CLTC—hypothyroidism	0.0013	0.00912	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CLTC—hypothyroidism	0.00126	0.00888	CbGpPWpGaD
Nimodipine—CYP3A4—liver—hypothyroidism	0.0012	0.00276	CbGeAlD
Nimodipine—CACNB2—Neuronal System—NEFL—hypothyroidism	0.00117	0.00819	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—CLTC—hypothyroidism	0.00111	0.00782	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—IYD—hypothyroidism	0.00108	0.00756	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VAV3—hypothyroidism	0.00107	0.00754	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—THRA—hypothyroidism	0.00106	0.00742	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—CLTC—hypothyroidism	0.00105	0.0074	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CLTC—hypothyroidism	0.000926	0.00651	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—CLTC—hypothyroidism	0.000926	0.0065	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ATP5O—hypothyroidism	0.000915	0.00643	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TPO—hypothyroidism	0.00086	0.00604	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VAV3—hypothyroidism	0.000858	0.00603	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VAV3—hypothyroidism	0.000835	0.00587	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CLTC—hypothyroidism	0.000794	0.00558	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VAV3—hypothyroidism	0.000766	0.00538	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NKX2-5—hypothyroidism	0.000753	0.00529	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CLTC—hypothyroidism	0.000752	0.00528	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—THRB—hypothyroidism	0.000681	0.00478	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CLTC—hypothyroidism	0.000661	0.00464	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—IYD—hypothyroidism	0.000657	0.00462	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—IYD—hypothyroidism	0.000623	0.00437	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VAV3—hypothyroidism	0.000613	0.0043	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VAV3—hypothyroidism	0.000612	0.0043	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VAV3—hypothyroidism	0.000596	0.00419	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ATP5O—hypothyroidism	0.000559	0.00393	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—IYD—hypothyroidism	0.000547	0.00384	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ATP5O—hypothyroidism	0.000529	0.00372	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TPO—hypothyroidism	0.000526	0.00369	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VAV3—hypothyroidism	0.000524	0.00368	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TPO—hypothyroidism	0.000498	0.0035	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VAV3—hypothyroidism	0.000497	0.00349	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000477	0.00335	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ATP5O—hypothyroidism	0.000465	0.00327	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TPO—hypothyroidism	0.000437	0.00307	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VAV3—hypothyroidism	0.000436	0.00307	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VAV3—hypothyroidism	0.000436	0.00307	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TSHB—hypothyroidism	0.000398	0.0028	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000386	0.00271	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VAV3—hypothyroidism	0.000374	0.00263	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3C2A—hypothyroidism	0.000355	0.00249	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VAV3—hypothyroidism	0.000354	0.00249	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VAV3—hypothyroidism	0.000311	0.00219	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SLC5A5—hypothyroidism	0.000298	0.00209	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TSHB—hypothyroidism	0.000243	0.00171	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IYD—hypothyroidism	0.000242	0.0017	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TSHB—hypothyroidism	0.00023	0.00162	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000222	0.00156	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3C2A—hypothyroidism	0.000217	0.00152	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ATP5O—hypothyroidism	0.000206	0.00145	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3C2A—hypothyroidism	0.000205	0.00144	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—POMC—hypothyroidism	0.000205	0.00144	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TSHB—hypothyroidism	0.000202	0.00142	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TPO—hypothyroidism	0.000194	0.00136	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC5A5—hypothyroidism	0.000182	0.00128	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3C2A—hypothyroidism	0.00018	0.00127	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00018	0.00126	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC5A5—hypothyroidism	0.000172	0.00121	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—POMC—hypothyroidism	0.000156	0.0011	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC5A5—hypothyroidism	0.000152	0.00106	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IYD—hypothyroidism	0.000113	0.000791	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ATP5O—hypothyroidism	9.57e-05	0.000672	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—POMC—hypothyroidism	9.54e-05	0.00067	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—POMC—hypothyroidism	9.53e-05	0.000669	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—POMC—hypothyroidism	9.02e-05	0.000634	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TPO—hypothyroidism	9e-05	0.000632	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TSHB—hypothyroidism	8.96e-05	0.00063	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	7.99e-05	0.000561	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—POMC—hypothyroidism	7.93e-05	0.000557	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A5—hypothyroidism	6.71e-05	0.000471	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TSHB—hypothyroidism	4.17e-05	0.000293	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.71e-05	0.000261	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—POMC—hypothyroidism	3.51e-05	0.000247	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.12e-05	0.000219	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—POMC—hypothyroidism	1.63e-05	0.000115	CbGpPWpGaD
